Peng Xu

Title: Peng Xu - Innovator in Sustained-Release Drug Delivery

Introduction

Peng Xu is a notable inventor based in Zhuhai, China. He has made significant contributions to the field of pharmaceuticals, particularly in drug delivery systems. His innovative work focuses on the development of sustained-release formulations that enhance the efficacy of medications.

Latest Patents

Peng Xu holds a patent for an "Aripiprazole sustained-release microsphere and preparation method therefor." This invention provides a novel microsphere formulation that comprises aripiprazole and polylactide-glycolide. The microsphere features a spherical reticular skeleton structure with reticular micropores distributed across its surface, allowing for the encapsulation of aripiprazole within these micropores. The average particle diameter of the microsphere is less than 20 μm, making it suitable for administration through a 5 gauge needle. The content of aripiprazole in the microsphere ranges from 65% to 80% of its total weight.

Career Highlights

Peng Xu is associated with Zhuhai Livzon Microsphere Technology Co. Ltd., where he applies his expertise in drug formulation and delivery systems. His work has been instrumental in advancing the capabilities of sustained-release medications, which are crucial for improving patient compliance and therapeutic outcomes.

Collaborations

Peng Xu collaborates with colleagues such as Bin Chen and Xia Yin, who contribute to the research and development efforts at Zhuhai Livzon Microsphere Technology Co. Ltd. Their teamwork fosters an environment of innovation and excellence in pharmaceutical technology.

Conclusion

Peng Xu's contributions to the field of sustained-release drug delivery exemplify the importance of innovation in pharmaceuticals. His patented microsphere technology represents a significant advancement in medication delivery systems, promising improved therapeutic efficacy for patients.